Literature DB >> 8335497

Selective decontamination of the digestive tract (SDD) does not prevent the formation of microbial biofilms on endotracheal tubes.

C G Adair1, S P Gorman, F B O'Neill, B McClurg, E C Goldsmith, C H Webb.   

Abstract

The purpose of selective decontamination of the digestive tract (SDD) is to eradicate potentially disease-producing micro-organisms from the oropharynx and gastro-intestinal tract of intensive care unit (ICU) patients, thereby reducing the incidence of nosocomial sepsis, particularly pneumonia. Microbial biofilms form on endotracheal (ET) tubes even when SDD is being administered and may represent a persistent focus for infection. The aim of this investigation was to determine the susceptibilities of organisms adherent to ET tubes to SDD antibiotics (amphotericin B, tobramycin and polymyxin) and to measure the concentrations of these agents in the tracheal aspirates of 11 patients who were being mechanically ventilated. Following extubation, a section was cut from the tip of each ET tube and any adherent microorganisms subsequently isolated were identified and their MICs determined. Samples of tracheal aspirate were obtained three hours after administration of the SDD regimen and the concentrations of the constituent antimicrobials were measured. Enterobacteriaceae were not recovered from any of the tubes but six strains of Staphylococcus aureus, three Pseudomonas spp., three enterococci and four yeasts were isolated. Wide variations in the concentrations of all antibiotics were observed and in many cases they were below the MICs for the organisms isolated. In particular, tobramycin concentrations were uniformly less than the median MIC for the S. aureus isolates and this may account for the predominance of Gram-positive bacteria adherent to the ET tubes. Microbial biofilms attached to these tubes may have a role in the pathogenesis of nosocomial pneumonia in ICU patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335497     DOI: 10.1093/jac/31.5.689

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

Review 1.  Technologic advances in endotracheal tubes for prevention of ventilator-associated pneumonia.

Authors:  Juan F Fernandez; Stephanie M Levine; Marcos I Restrepo
Journal:  Chest       Date:  2012-07       Impact factor: 9.410

2.  The antimicrobial effect of Octenidine-dihydrochloride coated polymer tracheotomy tubes on Staphylococcus aureus and Pseudomonas aeruginosa colonisation.

Authors:  Michaela Zumtobel; Ojan Assadian; Matthias Leonhard; Maria Stadler; Berit Schneider
Journal:  BMC Microbiol       Date:  2009-07-25       Impact factor: 3.605

3.  Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.

Authors:  D E Ghannam; G H Rodriguez; I I Raad; A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 3.267

4.  Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept.

Authors:  Sara Gil-Perotin; Paula Ramirez; Veronica Marti; Jose Miguel Sahuquillo; Eva Gonzalez; Isabel Calleja; Rosario Menendez; Juan Bonastre
Journal:  Crit Care       Date:  2012-05-23       Impact factor: 9.097

5.  Endotracheal tube biofilm translocation in the lateral Trendelenburg position.

Authors:  Gianluigi Li Bassi; Laia Fernandez-Barat; Lina Saucedo; Valeria Giunta; Joan Daniel Marti; Otavio Tavares Ranzani; Eli Aguilera Xiol; Montserrat Rigol; Ignasi Roca; Laura Muñoz; Nestor Luque; Mariano Esperatti; Maria Adela Saco; Jose Ramirez; Jordi Vila; Miguel Ferrer; Antoni Torres
Journal:  Crit Care       Date:  2015-02-27       Impact factor: 9.097

6.  Eradication of P. aeruginosa biofilm in endotracheal tubes based on lock therapy: results from an in vitro study.

Authors:  María Jesús Pérez-Granda; María Consuelo Latorre; Beatriz Alonso; Javier Hortal; Rafael Samaniego; Emilio Bouza; María Guembe
Journal:  BMC Infect Dis       Date:  2017-12-04       Impact factor: 3.090

7.  Selective digestive decontamination solution used as "lock therapy" prevents and eradicates bacterial biofilm in an in vitro bench-top model.

Authors:  María Jesús Pérez-Granda; Beatriz Alonso; Ricardo Zavala; María Consuelo Latorre; Javier Hortal; Rafael Samaniego; Emilio Bouza; Patricia Muñoz; María Guembe
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-23       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.